Pharmaceutical regulation and regulatory science
4 European H2020 organizations list this as part of their work — 4 as their primary capability.
Most active in this area
- BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE
Germany's federal drug and medical device regulatory authority, contributing regulatory science and health data standardization expertise to European research consortia.
“Coordinated STARS (regulatory science training), led UNICOM work on IDMP drug identification standards, and contributed to X-eHealth record frameworks.”
PrimaryDE8 projects - AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS
Spain's national medicines agency, contributing regulatory expertise to European drug standardisation, pharmacovigilance, and cross-border eHealth projects.
“STARS focused on regulatory science training, WEB-RADR 2 on pharmacovigilance, and UNICOM on drug identification standards (IDMP) — all core regulatory functions.”
PrimaryES7 projects - INFARMED - AUTORIDADE NACIONAL DO MEDICAMENTO E PRODUTOS DA SAUDE IP
Portugal's national medicines authority, contributing pharmaceutical regulatory expertise to EU drug identification, eHealth, and personalised medicine projects.
“STARS focused on strengthening regulatory science training, while UNICOM addresses standardised drug identification (IDMP) under regulatory frameworks.”
PrimaryPT3 projects - LAKEMEDELSVERKET
Sweden's national medicines regulatory authority, specializing in IDMP standardization, pharmaceutical eHealth data, and cross-border medicine identification.
“Both STARS and UNICOM draw on MPA's core mandate as a national medicines regulator, with STARS explicitly focused on strengthening regulatory science training across academia.”
PrimarySE2 projects